Target (CBDY) Depreciation and Depletion (2017 - 2021)
Target (CBDY) reported Depreciation and Depletion of $864764.0 for Q4 2021, up 430.76% year-over-year from $162929.0 in Q4 2020, and up 304.24% quarter-over-quarter from -$423408.0 in Q3 2021.
Target (CBDY) Depreciation and Depletion (2017 - 2021) Analysis & Trends
Target (CBDY) has 4 years of Depreciation and Depletion data on file, last reported at $864764.0 in Q4 2021.
- Depreciation and Depletion for Q4 2021 came in at $864764.0, up 430.76% year-over-year; the trailing twelve-month figure through Dec 2021 was $904516.0 (up 341.7% YoY), and the FY2021 annual result was $904516.0, up 300.96% from the prior year.
- Depreciation and Depletion advanced to $864764.0 in Q4 2021 per CBDY's latest filing, from -$423408.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $864764.0 in Q4 2021 and troughed at -$423408.0 in Q3 2021.
- A 4-year average of $95146.7 and a median of $29208.5 in 2019 frame the typical range for Depreciation and Depletion.
- On a YoY basis, Depreciation and Depletion climbed as much as 936.9% in 2021 and fell as far as 2231.86% in 2021.
- A 4-year view of Depreciation and Depletion shows it stood at $3440.0 in 2017, then tumbled by 2220.73% to -$72953.0 in 2019, then jumped by 323.33% to $162929.0 in 2020, then soared by 430.76% to $864764.0 in 2021.
- Business Quant data shows CBDY's Depreciation and Depletion at $864764.0 in Q4 2021, -$423408.0 in Q3 2021, and $235156.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 864,764.00 |
| Dec 31, 2021 | 864,764.00 |
| Sep 30, 2021 | -423,408.00 |
| Sep 30, 2021 | -423,408.00 |
| Jun 30, 2021 | 235,156.00 |
| Jun 30, 2021 | 235,156.00 |
| Mar 31, 2021 | 228,004.00 |
| Mar 31, 2021 | 228,004.00 |
| Dec 31, 2020 | 162,929.00 |
| Dec 31, 2020 | 162,929.00 |
| Sep 30, 2020 | 19,861.00 |
| Sep 30, 2020 | 19,861.00 |
| Mar 31, 2020 | 21,989.00 |
| Mar 31, 2020 | 21,989.00 |
| Dec 31, 2019 | -72,953.00 |
| Dec 31, 2019 | -72,953.00 |
| Sep 30, 2019 | 50,643.00 |
| Sep 30, 2019 | 50,643.00 |
| Jun 30, 2019 | 36,428.00 |
| Jun 30, 2019 | 36,428.00 |